autoimmune disease - search results

Karen Lee Morrissette and Jean C. Pfau from the Center for Asbestos-Related Disease discuss the clinical presentation and complexity of the autoimmune disease progression among those exposed to Libby Amphibole.

Andrew Mackie, VP Business Development tells us how Imcyse, a Belgian immunotherapy expert, seeks a curative approach to severe autoimmune diseases.

University of Perugia’s Ursula Grohmann and Antonio Macchiarulo share the work of the DIDO project in understanding cancer and autoimmune disease therapies

Multiple sclerosis (MS) is a disease that impacts the central nervous system, affecting everything we do. For many patients, the main question is: how do I confront this life-changing condition?

Jean Pfau received her Ph.D. in Microbiology/Biochemistry at the University of Montana Her post-doctoral training fostered her true passion for inflammatory and autoimmune diseases, which became her research focus. In 2001, Dr. Pfau joined a distinguished team of researchers from around the country to explore the health effects of asbestos,...

Jean C. Pfau is an immunotoxicologist with a PhD in Microbiology and Biochemistry. Dr Pfau currently serves as a scientific consultant for the Center for Asbestos Related Disease (CARD) in Libby, Montana.

Rhett Reichard, PhD and Keri C. Smith, PhD from Saba University School of Medicine, says that while multiple sclerosis is a debilitating disease, new treatments offer hope.

The number of people contracting autoimmune diorders in the United Kingdom is growing, including diseases like type 1 diabetes and rheumatoid arthritis. But why?

Researchers are developing a new Alzheimer's disease detection sensor that can be used in the early stages of Alzheimers and a number of other diseases.

The Algae4IBD project is studying the potential of probiotics and algae-derived prebiotics as a treatment for inflammatory bowel disease.

Department of Biochemistry - Microbiology and Immunology - University of SaskatchewanCan we now envisage antigen-specific therapies to prevent and treat organ-specific autoimmune diseases, such as autoimmune diabetes?

Rick Goodman, University of Nebraska, discusses food allergy risk assessments for new foods in different countries

A new study shows promise for future therapies for blinding eye diseases, uveitis and multiple sclerosis.

Isabelle Ote and Valérie Barette, Project Leaders at Belgian immunotherapy expert Imcyse, discuss its next phase of growth, and how to apply ImotopeTM technology to the treatment of MS.

János G. Filep, MD from the University of Montreal and Maisonneuve-Rosemont Hospital in Canada, discusses targeting immune mechanisms underlying cardiovascular diseases.

Stephen C Clark, from Newcastle upon Tyne Hospitals NHS Foundation Trust and University of Northumbria in the UK explains idiopathic pulmonary fibrosis, a type of lung disease.

Andrew Taylor, Professor of Ophthalmology, highlights research to understand the molecules that mediate ocular immune privilege so they can be adapted for chronic autoimmune uveitis.

Chairman of The Pernicious Anaemia Society, Martyn Hooper MBE lifts the lid on the history, causes and diagnosis of the world’s forgotten disease From the time it was first described in the mid-nineteenth century, the cause and treatment of Pernicious Anaemia became the subject of some of the most inquisitive...

University of Oulu’s Professor Riitta Veijola discusses the impact of Type 1 diabetes on society and the challenges associated with tackling the disease

Professor Pierre Ronco describes advances in our understanding of membranous nephropathy and the promise of precision medicine to treat the disease A rare disease which affects the kidney, membranous nephropathy is the second-most common cause of nephrotic syndrome, which is characterised by massive protein loss in the urine. The consequence...